EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - Nature reviews Clinical oncology, 2017 - nature.com
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - 2017 - dspace.mit.edu
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity-that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity-that is, the …
[HTML][HTML] EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - Nature reviews. Clinical oncology, 2017 - ncbi.nlm.nih.gov
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - Nature Reviews Clinical Oncology, 2017 - go.gale.com
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity--that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity--that is, the …
[引用][C] EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - Nature Reviews Clinical Oncology, 2017 - cir.nii.ac.jp
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF][PDF] EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - NATURE REVIEWS| CLINICAL …, 2017 - researchgate.net
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
[PDF][PDF] EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - core.ac.uk
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
T Shibue, RA Weinberg - Nature reviews. Clinical Oncology, 2017 - europepmc.org
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
T Shibue, RA Weinberg - Nature reviews. Clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity-that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity-that is, the …
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
T Shibue, RA Weinberg - Nature reviews. Clinical Oncology, 2017 - europepmc.org
The success of anticancer therapy is usually limited by the development of drug resistance.
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …
Such acquired resistance is driven, in part, by intratumoural heterogeneity—that is, the …